Lucid Pharma recalls 69k bottles of antidepressant over quality issues

Lucid Pharmaceuticals recalled more than 69,000 bottles of its extended-release antidepressant drug cenlafaxine hydrochloride over quality concerns.

Here are three things to know.

  1. Lucid launched the nationwide voluntary recall June 1 after receiving complaints from pharmacists about melted drug capsules.

  1. The recall applies to 30-count and 90-count bottles of the antidepressant.

  1. The Food and Drug Administration announced the recall last week, labeling it as a Class II event, meaning the quality issue poses an intermediate threat of illness or death.

More articles on supply chain:

Why this drugmaker invests in clean coal
FDA approves Shire's ADHD drug: 3 things to know
Dr. Scott Gottlieb: FDA will 'completely eliminate' orphan drug backlog

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars